Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010

Eurosurveillance

Volumn 16, Issue 48, 2011, Pages

  Wiessing, L ^a   Likatavicius, G ^b   Hedrich, D ^a   Guarita, B ^a   van de Laar, M J ^b   Vicente, J ^a  

^a EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION   (Portugal)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EPIDEMIC; EUROPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RATE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; OPIATE SUBSTITUTION TREATMENT; PREVALENCE; VIRUS TRANSMISSION;

EID: 83255165444     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wiessing L, Guarita B, Giraudon I, Brummer-Korvenkontio H, Salminen M, Cowan SA. European monitoring of notifications of hepatitis C virus infection in the general population and among injecting drug users (IDUs) the need to improve quality and comparability. Euro Surveill. 2008;13(21):pii=18884. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18884
2. Hatzakis A, Wait S, Bruix J, Buti M, Carballo M, Cavaleri M, et al. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference. J Viral Hepat. 2011;18 Suppl 1:1-16.
3. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 2011 Annual Report on the state of the drugs problem in Europe. Lisbon:EMCDDA;2011. Available from:http://www.emcdda.europa.eu/attachements.cfm/att_143743_EN_EMCDDA_AR2011_EN.pdf
4. Pharris A, Wiessing L, Sfetcu O, Hedrich D, Botescu A, Fotiou A, et al. Human immunodeficiency virus in injecting drug users in Europe following a reported increase of cases in Greece and Romania, 2011. Euro Surveill. 2011;16(48):pii=20032. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20032
5. European Centre for Disease Prevention and Control (ECDC), World Health Organization Regional Office for Europe. HIV/AIDS Surveillance in Europe: 2010. Stockholm: ECDC; 2011. Available from: http://ecdc.europa.eu/en/publications/Publications/111129_SUR_Annual_HIV_Report.pdf
6. Wiessing L, van de Laar MJ, Donoghoe MC, Guarita B, Klempová D, Griffiths P. HIV among injecting drug users in Europe: increasing trends in the East. Euro Surveill. 2008;13(50):pii=19067. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19067
7. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Statistical Bulletin 2011. Lisbon:EMCDDA. [Accessed 1 Dec 2011]. Available from: http://www.emcdda.europa.eu/stats11/drid
8. Vickerman P, Hickman M, May M, Kretzschmar M, Wiessing L. Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis. Addiction. 2010;105(2):311-8.
9. European Centre for Disease Prevention and Control (ECDC), European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Joint ECDC and EMCDDA rapid risk assessment: HIV in Injecting Drug Users in the EU, following a reported increase of cases in Romania and Greece. ECDC/EMCDDA; 2011. Restricted-access document.
10. Malliori, M. (2011), Early-warning message to EMCDDA on increased HIV transmission in IDUs in Greece, EMCDDA early-warning system report, July 2011.
11. Botescu A, Abagiu A. (2011), Early-warning message to EMCDDA on increased HIV transmission in IDUs in Romania, EMCDDA early-warning system report, November 2011.
12. Malliori M, Terzidou M, Paraskevis D, Hatzakis A. HIV/AIDS among IDUs in Greece: report of a recent outbreak and initial response policies. Lisbon:European Monitoring Centre for Drugs and Drug Addiction;2011. [Accessed 1 Dec 2011]. Available from: http://www.emcdda.europa.eu/news/2011/update1/greek-report
13. Paraskevis D, Nikolopoulos G, Tsiara C, Paraskeva D, Antoniadou A, Lazanas M, et al. HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report. Euro Surveill. 2011;16(36):pii=19962. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19962
14. European Centre for Disease Prevention and Control (ECDC), European Centre for Monitoring of Drugs and Drug Addiction. Prevention and control of infectious diseases among people who inject drugs. Stockholm:ECDC;2011. Available from: http://www.ecdc.europa.eu/en/publications/Publications/111012_Guidance_ECDC-EMCDDA.pdf
15. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Health and social responses an overview of the methods and definitions used. Lisbon:EMCDDA. [Accessed 1 Dec 2011]. Available from: http://www.emcdda.europa.eu/stats11/hsr/methods
16. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Figure HSR-1. Opioid substitution treatment clients as a percentage of the estimated number of problem opioid users, 2009 or most recent year available. Lisbon:EMCDDA. [Accessed 1 Dec 2011]. Available from: http://www.emcdda.europa.eu/stats11/hsrfig1
17. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Figure HSR-3. Syringes distributed through specialised programmes per estimated IDU in 2009 or most recent year. [Accessed 1 Dec 2011]. Available from: http://www.emcdda.europa.eu/stats11/hsrfig3
18. Reintjes R, Wiessing L. 2nd-generation HIV surveillance and injecting drug use: uncovering the epidemiological ice-berg. Int J Public Health. 2007;52(3):166-72.
19. Van Den Berg C, Smit C, Van Brussel G, Coutinho R, Prins M; Amsterdam Cohort. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction. 2007;102(9):1454-62.
20. Hagan H, Pouget ER, Des Jarlais DC. A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. J Infect Dis. 2011;204(1):74-83.
21. Turner K, Hutchinson S, Vickerman P, Hope V, Craine N, Palmateer N, et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction. 2011;106(11):1978-88.